Candida albicans phosphomannoprotein adhesion as a vaccine

Details Candida albicans phosphomannoprotein adhesion as a vaccine Candida albicans phosphomannoprotein adhesion as a vaccine

1995-06-07

1996-11-26

Housel, James C.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fungus, except allergen, or component thereof or substance...

4241841, A61K 3900

Patent

active

055783090

ABSTRACT:
A composition, pharamaceutical composition, vaccine and method for the treatment of disseminated candidiasis due to infection by C. albicans. The composition includes phosphomannoprotein which contains adhesins from C. albicans.

REFERENCES:
patent: 4310514 (1982-01-01), Durette
patent: 4315913 (1982-02-01), Durette
patent: 4323560 (1982-04-01), Baschang et al.
patent: 4368190 (1983-01-01), Shen et al.
patent: 4397838 (1983-08-01), d'Hinterland et al.
patent: 4678748 (1987-07-01), Sutka et al.
patent: 4732763 (1988-03-01), Beck et al.
patent: 5032404 (1991-07-01), Lopez-Berenstein et al.
patent: 5288639 (1994-02-01), Burnie et al.
Cutler, J. E., et al., "Antigenic variability of Candida albicans cell surface." Curr. Top. Med. Mycol. 5:27-47; 1994.
Kanbe, T. et al., "Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue." Infect. Immun., 61:2578-2584; 1993.
Kobayashi, H., et al., "Structural study of cell wall phosphomannan of Candida albicans NIH B--792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid--labile oligomannosyl residues." Arch. Biochem. Biophys., 278:195-204; 1990.
Li, R. K., et al., "chemical definition of an epitope/adhesin molecule on Candida albicans." J. Biol. Chem., 268:18293-18299; 1993.
Matthews, R., et al., "Acquired immunity to systemic candidiasis in immunodeficient mice: Role of antibody to heat-shock protein 90." J. Infect. Dis., 166:1193-1194; 1992.
Matthews, R. C., et al., "Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis." Immunol., 74:20-24; 1991.
Mourad, S., et al., "Active immunization of mice against Candida albicans." Proc. Soc. Exp. Biol. Med., 106:570-572; 1961.
Sieck et al., Protection against murine disseminated candidiasis mediated by a C. albicans-specific T-cell line. Infect. Immun. 61:3540-3543, 1993.
Scheld, W. M et al, Infect. & Immunity, Jun. 1983, pp. 950-955.
Kanbe, T et al. Infect. & Immunity, May 1994, pp. 1662-1668.
Matthews, R et al, Lancet, Jul. 30, 1988, pp. 263-265.
Klotz, S. A et al, Infection + Immunity, Oct. 1983, pp. 374-384.
Torosantucci et al, J Gen Microbiol, 1990, 136, pp. 1421-1428.

Affiliated with

Also associated with

Rating

Candida albicans phosphomannoprotein adhesion as a vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Candida albicans phosphomannoprotein adhesion as a vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Candida albicans phosphomannoprotein adhesion as a vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1971131